Mpox: Why Clade Ib Still Matters
Mpox became widely known during the 2022 global outbreak, but the virus had been known for decades before that. It belongs to the orthopoxvirus family, the same broad family as smallpox virus, though mpox is a different disease. The 2022 outbreak was mainly caused by clade IIb, but more recent global attention has focused on clade I and clade Ib, which have continued to spread in parts of Africa and have appeared in several countries through travel or local transmission networks.
Mpox is not spread like measles or COVID-19. It usually requires close contact, such as skin-to-skin contact with lesions, contact with contaminated materials, or close intimate exposure. That is why outbreaks often occur in social or sexual networks where close contact is common. Travel can also move the virus from one region to another before public health teams detect it.
Symptoms may include fever, swollen lymph nodes, muscle aches, fatigue, and rash. The rash can appear as bumps, blisters, or painful lesions. Some people have mild disease, but mpox can be more serious in children, pregnant people, immunocompromised individuals, and people with advanced HIV.
Prevention includes avoiding close contact with people who have symptoms, not sharing bedding or towels during illness, seeking testing if rash or exposure occurs, and following public health guidance. For people at increased risk, vaccination is an important tool. CDC recommends JYNNEOS as a two-dose vaccine, with the second dose given 4 weeks after the first. CDC notes that two doses provide the best protection, and available data suggest two-dose effectiveness is higher than one-dose protection.
Treatment is mainly supportive for mild cases. Some antiviral or investigational treatments may be considered for severe disease or high-risk patients under medical guidance, but prevention and early diagnosis remain critical.
Take-home message: Mpox is controllable when communities combine accurate information, rapid testing, contact tracing, respectful public health outreach, and vaccination for those at higher risk.
Comments